Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Clinical Utility of Tumor Markers
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer
CA-19-9 - Diagnostic Kit
SciELO - Brasil - Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer Further evidence of the prognostic role of pretreatment levels of CA 19-9
Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
CA 19-9 Antigen - an overview | ScienceDirect Topics
Tumor Markers in Pancreatic Cancer: 2013
Tumor Marker Control | Fujirebio
Tumour marker CA 19-9 - Pancreatic Cancer - little known - little heeded
Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports